Lataa...
Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients
The local renin-angiotensin system promotes angiogenesis and vascular proliferation via expression of vascular endothelial growth factor or epidermal growth factor receptor. We hypothesized that angiotensin II type-1 receptor blockers (ARBs) in combination with bevacizumab (Bev) may improve clinical...
Tallennettuna:
| Julkaisussa: | Mol Clin Oncol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4665652/ https://ncbi.nlm.nih.gov/pubmed/26807236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.630 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|